Preimplantation Genetic Testing for Aneuploidies in Patients With Recurrent Implantation Failure

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-40
SponsorUniversitaire Ziekenhuizen KU Leuven

About this trial

Assessing whether Preimplantation Genetic Testing for Aneuploidy (PGT-A) can increase the ongoing pregnancy rate per transferred embryo and can decrease the time to pregnancy and miscarriage rate in patients with Recurrent Implantation Failure (RIF)

Eligibility criteria

Qualifiers

Women with recurrent implantation failure (previous transfer of least 4 good quality embryos in at least 3 fresh or frozen cycles)

BMI < 35

Normal hysteroscopy

Disqualifiers

thin endometrium in previous cycles (<6mm), endometriosis ASRM score III-IV, premature ovarian failure (POF, Bologna criteria), abnormal karyotype, donor oocytes or embryos, PGT-M

Trial design

Treatments tested in this trial

  • PGT-A
  • Control

Treatment groups

100 Participants
are divided into 2 treatment groups